Analysis of published microarray data revealed that SMAD2, SMAD3 and SMAD4 mRNA levels decrease during prostate tumorigenesis, implying that loss of their expression could contribute to the progression of PIN to localized carcinoma and then to metastasis. This evidence concerns the gene SMAD2 and prostate intraepithelial neoplasia.